Galina Goloverda PhD

Galina Goloverda PhD

Professor

A Theranostic Agent Construction:     Development of New Strategies for Peptide Conjugation.

We are developing novel magnetic theranostic agents based on ultra-small superparamagnetic nanoparticulate maghemite covered with covalently attached non-polymeric amphiphilic organic shell.  Organic shell termini are being conjugated with a peptide for cancerous cells’ recognition.

Selected Publications:

(a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces. Rajesh Komati, Carl Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir Kolesnichen-ko, Chemistry-A European Journal, 2018, 24, 14824-14829.

(b) A Versatile Method of Ambient-Temperature Solvent Remov-al. Igor Kolesnichenko, Galina Goloverda and Vladimir Kole-snichenko, Organic Process Research & Development, 2020, 24, 25-31.

Topics & Keywords: Organic Linkers, Superparamagnetic nanoparticles, Cell labels, MRI Contrast Agents

ORCID: https://orcid.org/0000-0002-4903-8005

NCBI: http://www.ncbi.nlm.nih.gov/sites/myncbi/1xM95ZtRbOyQ/bibliography/48732709/public/?

LCRC Faculty

Weishan Huang, PhD
Translational Oncology
LSU - School of Veterinary Medicine
Thomas Huckaba PhD
Drug Discovery
Xavier University
Reza Izadpanah, DVM PhD
Cancer Biology
Tulane University School of Medicine
James Jackson PhD
Cancer Biology
Tulane University School of Medicine
Amelia Jernigan MD
Translational Oncology
LSU Health - New Orleans
Jun-yuan Ji PhD
Cancer Biology
Tulane University School of Medicine
Xiang Ji PhD
Population Sciences
Tulane University School of Medicine
Seetharama D Jois PhD
Translational Oncology
University of Louisiana Monroe
Lindsey Keith-Vincent EdD
Cancer Biology
Louisiana Tech University